Back to MW MARSHALL WACE, LLP

TARATARA
12 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PROTARA THERAPEUTICS INC

MARSHALL WACE, LLP holds 701,021 shares of TARA (PROTARA THERAPEUTICS INC), worth $2.7M as of 2026-Q2. The position was increased (+1281.8% shares). TARA represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$2.7M

Current Shares

701,021

Total Value Change

+$2M

Total Shares Change

+658,885

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
701,021
+1281.8%
$2.7M0.0%$3.82
42
2026-Q1
Decreased
50,731
-91.3%
$264,3080.0%$6.15
0
2025-Q4
Increased
584,528
+104.7%
$3.1M0.0%$5.25
43
2025-Q3
Decreased
285,586
-21.2%
$1.2M0.0%$4.41
0
2025-Q2
New
362,526
-
$1.1M0.0%$2.88
35
2024-Q4
Exited
0
-100.0%
$00.0%$5.28
0
2024-Q3
Unchanged
77,351
0.0%
$141,5520.0%$1.89
0
2024-Q2
New
77,351
-
$160,8900.0%$2.08
31
2021-Q4
Exited
0
-100.0%
$00.0%$6.54
0
2021-Q3
Decreased
15,190
-13.1%
$105,0000.0%$6.85
0
2021-Q2
Decreased
17,469
-58.5%
$170,0000.0%$9.83
0
2021-Q1
New
42,136
-
$664,0000.0%$14.10
34

Other major holders of TARA: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used